Effect group in full replicate Bioequivalence [Study Per­for­mance]

posted by dshah  – India/United Kingdom, 2022-05-12 13:46 (270 d 18:15 ago) – Posting: # 22973
Views: 567

Hello Laura!
Generally fully replicate study will be useful for HVD or NTI. In both the condition, the Swt and Swr will play a role in BE acceptance (Particularly AUC). Assuming this- it is better to group according to date of administration of all periods.

Complete thread:

UA Flag
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
27 visitors (0 registered, 27 guests [including 10 identified bots]).
Forum time: 07:02 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz